SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Colinz Laboratories informs about press release

01 Feb 2024 Evaluate
Colinz Laboratories has informed that as required under regulation 47(3) of SEBI(LODR), Regulation, 2015, It has published its Quarterly results as on 31-12-2023 in Newspaper on 01-02-2024. The copy of the same is attached.

The above information is a part of company’s filings submitted to BSE.

Colinz Laboratories Share Price

49.50 1.77 (3.71%)
07-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1831.30
Dr. Reddys Lab 1307.00
Cipla 1361.00
Zydus Lifesciences 940.10
Lupin 2460.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×